145 related articles for article (PubMed ID: 31507133)
1. The Hormone KL1: A Regulator of Breast Cancer Cell Metabolism.
Davidov B; Shmulevich R; Shabtay A; Rubinek T; Wolf I
Isr Med Assoc J; 2019 Jul; 21(7):504. PubMed ID: 31507133
[TBL] [Abstract][Full Text] [Related]
2. Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure-Function Analysis.
Ligumsky H; Rubinek T; Merenbakh-Lamin K; Yeheskel A; Sertchook R; Shahmoon S; Aviel-Ronen S; Wolf I
Mol Cancer Res; 2015 Oct; 13(10):1398-407. PubMed ID: 26113466
[TBL] [Abstract][Full Text] [Related]
3. Klotho rewires cellular metabolism of breast cancer cells through alteration of calcium shuttling and mitochondrial activity.
Shmulevich R; Nissim TB; Wolf I; Merenbakh-Lamin K; Fishman D; Sekler I; Rubinek T
Oncogene; 2020 Jun; 39(24):4636-4649. PubMed ID: 32398866
[TBL] [Abstract][Full Text] [Related]
4. KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer.
Abramovitz L; Rubinek T; Ligumsky H; Bose S; Barshack I; Avivi C; Kaufman B; Wolf I
Clin Cancer Res; 2011 Jul; 17(13):4254-66. PubMed ID: 21571866
[TBL] [Abstract][Full Text] [Related]
5. Revealing the tumor suppressive sequence within KL1 domain of the hormone Klotho.
Abboud M; Merenbakh-Lamin K; Volkov H; Ben-Neriah S; Ligumsky H; Bronfeld S; Keren-Khadmy N; Giladi M; Shomron N; Wolf I; Rubinek T
Oncogene; 2024 Jan; 43(5):354-362. PubMed ID: 38040805
[TBL] [Abstract][Full Text] [Related]
6. Klotho suppresses colorectal cancer through modulation of the unfolded protein response.
Arbel Rubinstein T; Shahmoon S; Zigmond E; Etan T; Merenbakh-Lamin K; Pasmanik-Chor M; Har-Zahav G; Barshack I; Vainer GW; Skalka N; Rosin-Arbesfeld R; Varol C; Rubinek T; Wolf I
Oncogene; 2019 Feb; 38(6):794-807. PubMed ID: 30232408
[TBL] [Abstract][Full Text] [Related]
7. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
8. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.
Wolf I; Levanon-Cohen S; Bose S; Ligumsky H; Sredni B; Kanety H; Kuro-o M; Karlan B; Kaufman B; Koeffler HP; Rubinek T
Oncogene; 2008 Nov; 27(56):7094-105. PubMed ID: 18762812
[TBL] [Abstract][Full Text] [Related]
9. Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho.
Chen CD; Li Y; Chen AK; Rudy MA; Nasse JS; Zeldich E; Polanco TJ; Abraham CR
PLoS One; 2020; 15(1):e0226382. PubMed ID: 31929539
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
11. The Role of Alpha-Klotho as a Universal Tumor Suppressor.
Rubinek T; Wolf I
Vitam Horm; 2016; 101():197-214. PubMed ID: 27125743
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
Woo YM; Shin Y; Lee EJ; Lee S; Jeong SH; Kong HK; Park EY; Kim HK; Han J; Chang M; Park JH
PLoS One; 2015; 10(7):e0132285. PubMed ID: 26158266
[TBL] [Abstract][Full Text] [Related]
13. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
14. KL1 Domain of Longevity Factor Klotho Mimics the Metabolome of Cognitive Stimulation and Enhances Cognition in Young and Aging Mice.
Gupta S; Moreno AJ; Wang D; Leon J; Chen C; Hahn O; Poon Y; Greenberg K; David N; Wyss-Coray T; Raftery D; Promislow DEL; Dubal DB
J Neurosci; 2022 May; 42(19):4016-4025. PubMed ID: 35428698
[TBL] [Abstract][Full Text] [Related]
15. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
[TBL] [Abstract][Full Text] [Related]
16. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
[TBL] [Abstract][Full Text] [Related]
19. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.
Wright JD; An SW; Xie J; Yoon J; Nischan N; Kohler JJ; Oliver N; Lim C; Huang CL
FASEB J; 2017 Aug; 31(8):3574-3586. PubMed ID: 28442546
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Klotho Treatment on Atherogenesis, Blood Pressure, and Metabolic Parameters in Experimental Rodent Models.
Kamari Y; Fingrut O; Shaish A; Almog T; Kandel-Kfir M; Harats D; Rubinek T; Wolf I
Horm Metab Res; 2016 Mar; 48(3):196-200. PubMed ID: 25951321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
